drugset / Trial / NCT01803373

A Study to Assess the Relative Bioavailability of TMC207 Following Single-Dose Administrations of Two Pediatric Formulations in Healthy Adult Participants

NCT01803373

Phase 1 Completed 36 enrolled Janssen Infectious Diseases BVBA
RandomizedCrossoverOpen-labelTreatment

Summary

The purpose of this study is to test the relative bioavailability (extent and rate to which a drug is taken up by the body) of TMC207 following the administration of two pediatric formulations of TMC207 taken with and without food in healthy adult participants.

Timeline

Start
2013-04
Primary completion
2013-08
Completion
2013-08

Drugs

EvaluationDrugModalityDoseRoute
Subject Bedaquiline Small molecule 100 mg Oral

Indications

No indication recorded.